Patents by Inventor Ta-Chien Lu

Ta-Chien Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release carvedilol formulation
    Patent number: 8883207
    Abstract: A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: November 11, 2014
    Assignees: TSH Biopharm Corporation Ltd., Innopharmax, Inc.
    Inventors: Wei-Hua Hao, Tsung-Hsin Lin, Ta-Chien Lu
  • CONTROLLED RELEASE CARVEDILOL FORMULATION
    Publication number: 20120245212
    Abstract: A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.
    Type: Application
    Filed: September 29, 2010
    Publication date: September 27, 2012
    Applicants: INNOPHARMAX, INC., TSH BIOPHARM CORPORATION LTD.
    Inventors: Wei-Hua Hao, Tsung-Hsin Lin, Ta-Chien Lu